SCHEMBL26020164

SCHEMBL26020164

CN(C)c1ccc(C(C)(C)C)c(C(F)(F)F)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 2/20 0.45
CRHR1 P34998 5/20 0.43
ALDH1A1 P00352 3/20 0.39
ALOX15 P16050 3/20 0.39
TSHR P16473 3/20 0.39
HSD17B10 Q99714 2/20 0.39
JAK2 O60674 1/20 0.37
JAK1 P23458 1/20 0.37
JAK3 P52333 1/20 0.37
NR1H4 Q96RI1 1/20 0.37
TERT O14746 1/20 0.36
APP P05067 1/20 0.36
PDK2 Q15119 1/20 0.36
GAA P10253 1/20 0.34
CNR2 P34972 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
SLC2A1 P11166 1/20 0.33
SOS1 Q07889 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20034026 0.87 ALDH1A1 (0.46) ARCRHR1ALDH1A1ALOX15TSHR
SCHEMBL13990192 0.79 TSHR (0.48) ARCRHR1ALDH1A1ALOX15TSHR
SCHEMBL13528295 0.78 ALDH1A1 (0.40) ARCRHR1ALDH1A1ALOX15TSHR
SCHEMBL18517389 0.78 AR (0.46) ARCRHR1ALDH1A1ALOX15TSHR
SCHEMBL13528294 0.78 ALDH1A1 (0.40) ARCRHR1ALDH1A1ALOX15TSHR
SCHEMBL24687543 0.78 AR (0.46) ARCRHR1ALDH1A1ALOX15TSHR
SCHEMBL13763445 0.78 CRHR1 (0.48) ARCRHR1ALDH1A1ALOX15TSHR
SCHEMBL26223336 0.77 ALDH1A1 (0.43) ARALDH1A1ALOX15TSHRHSD17B10
SCHEMBL26223335 0.77 ALDH1A1 (0.43) ARCRHR1ALDH1A1ALOX15TSHR
SCHEMBL5451177 0.76 AR (0.45) ARCRHR1ALDH1A1ALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257382-A1 HETEROCYCLIC COMPOUND AND USE THEREOF WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD. (CN) 2023-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257382-A1 HETEROCYCLIC COMPOUND AND USE THEREOF TRPC5, TRPC1, GOT1 AR 3746/4885CRHR1 1344/4885ALDH1A1 2155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.